Agency Information Collection Activities: Proposed Collection; Request, 15475-15476 [2020-05612]
Download as PDF
Federal Register / Vol. 85, No. 53 / Wednesday, March 18, 2020 / Notices
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank indicated. The
applications will also be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than April 16, 2020.
A. Federal Reserve Bank of Atlanta
(Kathryn Haney, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. CapStar Financial Holdings, Inc.,
Nashville, Tennessee; to merge with
FCB Corporation, Manchester,
Tennessee, and thereby indirectly
acquire First National Bank of
Manchester, Manchester, Tennessee,
and The Bank of Waynesboro,
Waynesboro, Tennessee.
Board of Governors of the Federal Reserve
System, March 12, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–05534 Filed 3–17–20; 8:45 am]
jbell on DSKJLSW7X2PROD with NOTICES
BILLING CODE P
FEDERAL RETIREMENT THRIFT
INVESTMENT
Board Member Meeting
77 K Street NE, 10th Floor, Washington,
DC 20002
March 23, 2020, 10 a.m., Telephonic
VerDate Sep<11>2014
20:22 Mar 17, 2020
Jkt 250001
Open Session
1. Approval of the Minutes of the
February 24, 2020 Board Meeting
2. Monthly Reports
(a) Participant Activity Report
(b) Legislative Report
(c) Investment Performance
3. Quarterly Report: Vendor Risk
Management Update
4. OERM Annual Report
5. Enterprise Risk Management Update
6. 5 Year Lifecycle Funds Project
Update
7. Lifecycle Funds Study
Contact Person for More Information:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
Dated: March 12, 2020.
Megan Grumbine,
General Counsel, Federal Retirement Thrift
Investment Board.
[FR Doc. 2020–05616 Filed 3–17–20; 8:45 am]
BILLING CODE 6760–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Request
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Request for information (RFI).
AGENCY:
For the ‘‘Opioid Management
in Older Adults’’ project, AHRQ is
seeking to identify innovative
approaches to managing opioid
medications for chronic pain that are
particularly relevant for older adults.
Use of long-term opioid therapy in older
adults can be especially problematic
because of increased risks such as
delirium, falls, and dementia.
DATES: Information must be received by
April 25, 2020.
ADDRESSES: Written comments should
be submitted by email to: Opioids_
OlderAdults@abtassoc.com.
FOR FURTHER INFORMATION CONTACT:
Parivash Nourjah, Parivash.nourjah@
ahrq.gov, or 301–427–1106.
SUPPLEMENTARY INFORMATION: The
United States is in the midst of an
unprecedented opioid epidemic that is
affecting people from all walks of life.
Regulators and policy makers have
initiated many activities to curb the
epidemic, but relatively little attention
has been paid to the growing toll of
opioid use, opioid misuse and opioid
use disorder (OUD) among older adults.
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
15475
The opioid crisis in older adults is
strongly related to challenges in
prescription opioid management in this
population. Older adults have a high
prevalence of chronic pain and are
especially vulnerable to suffering
adverse events from opioid use, making
safe prescribing more challenging even
when opioids are an appropriate
therapeutic choice. Identifying adverse
effects due to opioid use, misuse or
abuse is complicated further by factors
such as co-occurring medical disorders
that can mimic the effects of opioid use.
There is also a risk of attributing clinical
findings in older adults (e.g. personality
changes, falls/balance problems,
difficulty sleeping, and heart problems)
to other conditions that are also
common with age. If adverse events due
to opioid prescriptions are identified,
finding appropriate alternatives for pain
management can be challenging if other
pharmacologic options (such as
NSAIDS) are contraindicated or
mobility issues limit access to other
therapeutic options.
Diagnosis of substance use disorders
is also more complicated in this
population. Clinicians may not associate
drug misuse or addiction with older
adults or they may be inadequately
trained in identification and treatment
of opioid misuse and OUD among older
adults, and hence may not monitor for
the signs of opioid use disorder in this
population.
Successfully optimizing the
prescribing and use of opioids in older
adults will require addressing the issue
at many points along the care
continuum where older adults may need
additional attention or a different
approach. AHRQ wants to identify
specific tools, strategies and approaches
to opioid management in older adults
throughout the breadth of the care
delivery continuum, from avoiding
opioid initiation to screening for opioid
misuse and opioid use disorder, as well
as approaches to opioid tapering in
older adults.
AHRQ is interested in all innovative
approaches that address the opioid
management concerns in older adults
listed above, but respondents are
welcome to address as many or as few
as they choose and to address additional
areas of interest not listed.
Strategies and approaches could come
from a variety of health care settings
including, but not limited to, primary
care and other ambulatory care clinics,
emergency departments, home health
care organizations, skilled nursing care
settings, and inpatient care. Other
sources of these strategies might include
health care payers, accountable care
organizations, and organizations that
E:\FR\FM\18MRN1.SGM
18MRN1
15476
Federal Register / Vol. 85, No. 53 / Wednesday, March 18, 2020 / Notices
provide external quality improvement
support. Some of the examples of the
types of innovations we are looking for
might be specific tools or workflows
that support providers to assess the risk/
benefit balance of opioids within a
multidisciplinary approach in pain
management; to optimize and monitor
the opioid prescribing when
appropriate, including tapering
strategies; to screen and treat for opioid
misuse or opioid use disorder; or to
involve family or other caregivers of an
older adult in conversations about
opioid safety. Descriptions of strategies
or approaches should include the
setting where it is deployed and the
type of patient population served.
This RFI is for planning purposes
only and should not be construed as a
policy, solicitation for applications, or
as an obligation on the part of the
Government to provide support for any
ideas in response to it. AHRQ will use
the information submitted in response
to this RFI at its discretion, and will not
provide comments to any respondent’s
submission. However, responses to the
RFI may be reflected in future
solicitation(s) or policies. Respondents
are advised that the Government is
under no obligation to acknowledge
receipt of the information received or
provide feedback to respondents with
respect to any information submitted.
No proprietary, classified, confidential
or sensitive information should be
included in your response. The
Government reserves the right to use
any non-proprietary technical
information in any resultant
solicitation(s). The contents of all
submissions will be made available to
the public upon request. Submitted
materials must be publicly available or
able to be made public.
Dated: March 12, 2020.
Virginia Mackay-Smith,
Associate Director, Office of the Director,
AHRQ.
[FR Doc. 2020–05612 Filed 3–17–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSKJLSW7X2PROD with NOTICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of change to public
meeting.
AGENCY:
VerDate Sep<11>2014
18:54 Mar 17, 2020
Jkt 250001
In response to recently issued
OPM guidance to agencies on reducing
non-essential travel, this notice
announces a change to a meeting of the
National Advisory Council for
Healthcare Research and Quality.
SUMMARY:
The meeting will be held on
Thursday, March 26, 2020, from 12:30
p.m. to 3:30 p.m.
DATES:
The meeting will now be
held virtually (via WebEx).
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland, 20857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
Closed captioning will be provided
during the WebEx. If another reasonable
accommodation for a disability is
needed, please contact the Food and
Drug Administration (FDA) Office of
Equal Employment Opportunity and
Diversity Management on (301) 827–
4840, no later than Thursday, March 19,
2020. The agenda, roster, and minutes
will be available from Ms. Heather
Phelps, Committee Management Officer,
Agency for Healthcare Research and
Quality, 5600 Fishers Lane, Rockville,
Maryland 20857. Ms. Phelps’ phone
number is (301) 427–1128.
SUPPLEMENTARY INFORMATION:
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
II. Agenda
On Thursday, March 26, 2020, the
Council meeting will convene at 12:30
p.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting is
open to the public and will be available
via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s recent accomplishments and
budget. The agenda will also include a
discussion about 21st Century Care and
AHRQ Data and Analytics Initiatives,
including Synthetic Data. The meeting
will adjourn at 3:30 p.m. For
information on accessing the WebEx, as
well as other meeting details, including
information on how to make a public
comment, please go to https://
www.ahrq.gov/news/events/nac/. The
final agenda will be available on the
AHRQ website no later than Thursday,
March 19, 2020.
Dated: March 12, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–05563 Filed 3–17–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB #0970–0509]
Expedited OMB Review and Public
Comment: Information Collection
Activity; Medical Complaint Form,
Contact Investigation Form: Non-TB
Illness, and Contact Investigation
Form: Active/Suspect TB
Office of Refugee Resettlement;
Administration for Children and
Families; Department of Health and
Human Services.
ACTION: Request for public comment.
AGENCY:
The Office of Refugee
Resettlement (ORR), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is requesting expedited
review of an information collection
request from the Office of Management
and Budget (OMB) and inviting public
comments on the proposed revisions.
The request consists of the addition of
questions to the Medical Complaint
Form to track instances of COVID–19.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
the Administration for Children and
SUMMARY:
E:\FR\FM\18MRN1.SGM
18MRN1
Agencies
[Federal Register Volume 85, Number 53 (Wednesday, March 18, 2020)]
[Notices]
[Pages 15475-15476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05612]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Request
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Request for information (RFI).
-----------------------------------------------------------------------
SUMMARY: For the ``Opioid Management in Older Adults'' project, AHRQ is
seeking to identify innovative approaches to managing opioid
medications for chronic pain that are particularly relevant for older
adults. Use of long-term opioid therapy in older adults can be
especially problematic because of increased risks such as delirium,
falls, and dementia.
DATES: Information must be received by April 25, 2020.
ADDRESSES: Written comments should be submitted by email to:
[email protected].
FOR FURTHER INFORMATION CONTACT: Parivash Nourjah,
[email protected], or 301-427-1106.
SUPPLEMENTARY INFORMATION: The United States is in the midst of an
unprecedented opioid epidemic that is affecting people from all walks
of life. Regulators and policy makers have initiated many activities to
curb the epidemic, but relatively little attention has been paid to the
growing toll of opioid use, opioid misuse and opioid use disorder (OUD)
among older adults.
The opioid crisis in older adults is strongly related to challenges
in prescription opioid management in this population. Older adults have
a high prevalence of chronic pain and are especially vulnerable to
suffering adverse events from opioid use, making safe prescribing more
challenging even when opioids are an appropriate therapeutic choice.
Identifying adverse effects due to opioid use, misuse or abuse is
complicated further by factors such as co-occurring medical disorders
that can mimic the effects of opioid use. There is also a risk of
attributing clinical findings in older adults (e.g. personality
changes, falls/balance problems, difficulty sleeping, and heart
problems) to other conditions that are also common with age. If adverse
events due to opioid prescriptions are identified, finding appropriate
alternatives for pain management can be challenging if other
pharmacologic options (such as NSAIDS) are contraindicated or mobility
issues limit access to other therapeutic options.
Diagnosis of substance use disorders is also more complicated in
this population. Clinicians may not associate drug misuse or addiction
with older adults or they may be inadequately trained in identification
and treatment of opioid misuse and OUD among older adults, and hence
may not monitor for the signs of opioid use disorder in this
population.
Successfully optimizing the prescribing and use of opioids in older
adults will require addressing the issue at many points along the care
continuum where older adults may need additional attention or a
different approach. AHRQ wants to identify specific tools, strategies
and approaches to opioid management in older adults throughout the
breadth of the care delivery continuum, from avoiding opioid initiation
to screening for opioid misuse and opioid use disorder, as well as
approaches to opioid tapering in older adults.
AHRQ is interested in all innovative approaches that address the
opioid management concerns in older adults listed above, but
respondents are welcome to address as many or as few as they choose and
to address additional areas of interest not listed.
Strategies and approaches could come from a variety of health care
settings including, but not limited to, primary care and other
ambulatory care clinics, emergency departments, home health care
organizations, skilled nursing care settings, and inpatient care. Other
sources of these strategies might include health care payers,
accountable care organizations, and organizations that
[[Page 15476]]
provide external quality improvement support. Some of the examples of
the types of innovations we are looking for might be specific tools or
workflows that support providers to assess the risk/benefit balance of
opioids within a multidisciplinary approach in pain management; to
optimize and monitor the opioid prescribing when appropriate, including
tapering strategies; to screen and treat for opioid misuse or opioid
use disorder; or to involve family or other caregivers of an older
adult in conversations about opioid safety. Descriptions of strategies
or approaches should include the setting where it is deployed and the
type of patient population served.
This RFI is for planning purposes only and should not be construed
as a policy, solicitation for applications, or as an obligation on the
part of the Government to provide support for any ideas in response to
it. AHRQ will use the information submitted in response to this RFI at
its discretion, and will not provide comments to any respondent's
submission. However, responses to the RFI may be reflected in future
solicitation(s) or policies. Respondents are advised that the
Government is under no obligation to acknowledge receipt of the
information received or provide feedback to respondents with respect to
any information submitted. No proprietary, classified, confidential or
sensitive information should be included in your response. The
Government reserves the right to use any non-proprietary technical
information in any resultant solicitation(s). The contents of all
submissions will be made available to the public upon request.
Submitted materials must be publicly available or able to be made
public.
Dated: March 12, 2020.
Virginia Mackay-Smith,
Associate Director, Office of the Director, AHRQ.
[FR Doc. 2020-05612 Filed 3-17-20; 8:45 am]
BILLING CODE 4160-90-P